- Home
- ATXS vs UHT Comparison
ATXS vs UHT Comparison
Compare ATXS & UHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- UHT
- Stock Information
- Founded
- ATXS 2008
- UHT 1986
- Country
- ATXS United States
- UHT United States
- Employees
- ATXS N/A
- UHT N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- UHT Real Estate Investment Trusts
- Sector
- ATXS Health Care
- UHT Real Estate
- Exchange
- ATXS Nasdaq
- UHT Nasdaq
- Market Cap
- ATXS 676.1M
- UHT 541.8M
- IPO Year
- ATXS 2015
- UHT N/A
- Fundamental
- Price
- ATXS $12.50
- UHT $40.32
- Analyst Decision
- ATXS Hold
- UHT
- Analyst Count
- ATXS 6
- UHT 0
- Target Price
- ATXS $24.33
- UHT N/A
- AVG Volume (30 Days)
- ATXS 936.9K
- UHT 84.6K
- Earning Date
- ATXS 11-12-2025
- UHT 10-27-2025
- Dividend Yield
- ATXS N/A
- UHT 7.46%
- EPS Growth
- ATXS N/A
- UHT N/A
- EPS
- ATXS N/A
- UHT 1.30
- Revenue
- ATXS $706,000.00
- UHT $100,898,000.00
- Revenue This Year
- ATXS N/A
- UHT N/A
- Revenue Next Year
- ATXS N/A
- UHT $0.81
- P/E Ratio
- ATXS N/A
- UHT $31.17
- Revenue Growth
- ATXS N/A
- UHT 1.00
- 52 Week Low
- ATXS $3.56
- UHT $34.56
- 52 Week High
- ATXS $12.72
- UHT $42.82
- Technical
- Relative Strength Index (RSI)
- ATXS 67.29
- UHT 64.78
- Support Level
- ATXS $12.31
- UHT $39.12
- Resistance Level
- ATXS $12.62
- UHT $40.16
- Average True Range (ATR)
- ATXS 0.23
- UHT 0.84
- MACD
- ATXS -0.17
- UHT 0.18
- Stochastic Oscillator
- ATXS 72.73
- UHT 98.52
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About UHT Universal Health Realty Income Trust
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.